Diagnos, Inc. (ADK.V)
0.41
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 15:35
Diagnos EPS Diluted (Quarterly) : -0.0098 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0098 |
| December 31, 2025 | -0.0099 |
| September 30, 2025 | -0.0107 |
| June 30, 2025 | -0.0109 |
| March 31, 2025 | -0.0131 |
| December 31, 2024 | -0.0129 |
| September 30, 2024 | -0.0124 |
| June 30, 2024 | -0.0092 |
| March 31, 2024 | -0.0108 |
| December 31, 2023 | -0.0111 |
| September 30, 2023 | -0.0104 |
| June 30, 2023 | -0.0106 |
| March 31, 2023 | -0.0104 |
| December 31, 2022 | -0.0074 |
| September 30, 2022 | -0.0075 |
| June 30, 2022 | -0.0103 |
| March 31, 2022 | -0.0105 |
| December 31, 2021 | -0.0088 |
| September 30, 2021 | -0.0081 |
| June 30, 2021 | -0.0106 |
| March 31, 2021 | -0.0094 |
| December 31, 2020 | -0.009 |
| September 30, 2020 | -0.0057 |
| June 30, 2020 | -0.0081 |
| March 31, 2020 | -0.0272 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0133 |
| September 30, 2019 | -0.0135 |
| June 30, 2019 | -0.0327 |
| March 31, 2019 | -0.0351 |
| December 31, 2018 | -0.053 |
| September 30, 2018 | -0.063 |
| June 30, 2018 | -0.0555 |
| March 31, 2018 | -0.10 |
| December 31, 2017 | -0.0316 |
| September 30, 2017 | -0.0485 |
| June 30, 2017 | -0.0291 |
| March 31, 2017 | -0.10 |
| December 31, 2016 | 0.0044 |
| September 30, 2016 | -0.10 |
| June 30, 2016 | -0.0648 |
| March 31, 2016 | -0.10 |
| December 31, 2015 | -0.10 |
| September 30, 2015 | -0.10 |
| June 30, 2015 | -0.10 |
| March 31, 2015 | -0.0644 |
| December 31, 2014 | -0.10 |
| September 30, 2014 | -0.10 |
| June 30, 2014 | -0.10 |
| March 31, 2014 | -0.10 |
| December 31, 2013 | -0.10 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Evokai Creative Labs, Inc. | -- |
| Arch Biopartners, Inc. | -0.0078 |
| Avricore Health, Inc. | -0.002 |
| Kane Biotech, Inc. | -0.0039 |
| CardioComm Solutions, Inc. | -0.001 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.184M |
| Revenue (Quarterly) | 0.0157M |
| Total Expenses (Quarterly) | 1.200M |
| Enterprise Value | 48.24M |
| Gross Profit Margin (Quarterly) | -2.24K% |
| Profit Margin (Quarterly) | -7.54K% |
| Earnings Yield | -10.07% |
| Normalized Earnings Yield | -10.12 |